PRL3 Promotes Cell Invasion and Proliferation by Down-regulation of Csk Leading to Src Activation*

Phosphatase of regenerating liver 3 (PRL3) is overexpressed in a variety of tumors, and high levels of PRL3 expression are associated with tumorigenesis and metastasis. Consistent with an oncogenic role for PRL3, we show that ectopic PRL3 expression promotes cell proliferation and invasion. However, little is known about the molecular basis for PRL3 function. Obtaining this knowledge is vital for understanding PRL3-mediated disease processes and for the development of novel anticancer therapies targeted to PRL3. Here we report that up-regulation of PRL3 activates the Src kinase, which initiates a number of signal pathways culminating in the phosphorylation of ERK1/2, STAT3, and p130Cas. The activation of these pathways likely contributes to the increased cell growth and motility of PRL3 cells. We provide evidence that PRL3 induces Src activation through down-regulation of Csk, a negative regulator of Src. Importantly, Src activation and Csk down-regulation are also observed in colon cancer cells expressing a higher level of PRL3. Thus, we have revealed a biochemical mechanism for the PRL3-mediated cell invasion and proliferation in which elevated PRL3 expression causes a reduction in Csk level, leading to Src activation.

[1]  G. O'Neill,et al.  Integrin signalling: a new Cas(t) of characters enters the stage. , 2000, Trends in cell biology.

[2]  Michael J. Eck,et al.  Three-dimensional structure of the tyrosine kinase c-Src , 1997, Nature.

[3]  K. Klinger,et al.  Alterations in Vascular Gene Expression in Invasive Breast Carcinoma , 2004, Cancer Research.

[4]  R. Jove,et al.  Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. , 1995, Science.

[5]  J. Li,et al.  PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. , 2003, Cancer research.

[6]  S. Nada,et al.  Csk defines the ability of integrin-mediated cell adhesion and migration in human colon cancer cells: implication for a potential role in cancer metastasis , 2004, Oncogene.

[7]  J. Blenis,et al.  ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions , 2004, Microbiology and Molecular Biology Reviews.

[8]  S. Courtneidge Activation of the pp60c‐src kinase by middle T antigen binding or by dephosphorylation. , 1985, The EMBO journal.

[9]  John Kuriyan,et al.  Crystal structure of the Src family tyrosine kinase Hck , 1997, Nature.

[10]  J. Cooper,et al.  Dephosphorylation or antibody binding to the carboxy terminus stimulates pp60c-src , 1986, Molecular and cellular biology.

[11]  N. Rahimi,et al.  c-Src Kinase Activity Is Required for Hepatocyte Growth Factor-induced Motility and Anchorage-independent Growth of Mammary Carcinoma Cells* , 1998, The Journal of Biological Chemistry.

[12]  A. Bardelli,et al.  PRL-3 Phosphatase Is Implicated in Ovarian Cancer Growth , 2005, Clinical Cancer Research.

[13]  A. Cox,et al.  PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. , 2006, Cancer research.

[14]  V. Diehl,et al.  Profiling of Hodgkin’s Lymphoma Cell Line L1236 and Germinal Center B Cells: Identification of Hodgkin’s Lymphoma-specific Genes , 2003 .

[15]  D. Crowell,et al.  Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases. , 1996, Cancer letters.

[16]  Ken Jacobson,et al.  MAP kinases and cell migration , 2004, Journal of Cell Science.

[17]  K. Kinzler,et al.  PRL-3 expression in metastatic cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  J. Darnell Transcription factors as targets for cancer therapy , 2002, Nature Reviews Cancer.

[19]  Timothy J. Yeatman,et al.  A renaissance for SRC , 2004, Nature Reviews Cancer.

[20]  E. Avizienyte,et al.  Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. , 2005, Current opinion in cell biology.

[21]  R. Riggins,et al.  Functions of the adapter protein Cas: signal convergence and the determination of cellular responses , 2001, Oncogene.

[22]  Joanna M. Sasin,et al.  Protein Tyrosine Phosphatases in the Human Genome , 2004, Cell.

[23]  Qiang Xu,et al.  Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. , 2004, The American journal of pathology.

[24]  S. Ogawa,et al.  A novel signaling molecule, p130, forms stable complexes in vivo with v‐Crk and v‐Src in a tyrosine phosphorylation‐dependent manner. , 1994, The EMBO journal.

[25]  Xinyang Zheng,et al.  Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase , 1992, Nature.

[26]  D. Critchley Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion. , 2004, Biochemical Society transactions.

[27]  Hua Yu,et al.  The STATs of cancer — new molecular targets come of age , 2004, Nature Reviews Cancer.

[28]  Michael A. Choti,et al.  A Phosphatase Associated with Metastasis of Colorectal Cancer , 2001, Science.

[29]  D. V. Von Hoff,et al.  PRL phosphatases as potential molecular targets in cancer , 2005, Molecular Cancer Therapeutics.

[30]  K. Klinger,et al.  Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function , 2006, Molecular Cancer Therapeutics.

[31]  A. Bardelli,et al.  PRL-3: A phosphatase for metastasis? , 2004, Cancer biology & therapy.

[32]  Y. Shiratori,et al.  Reduced C‐terminal Src kinase (Csk) activities in hepatocellular carcinoma , 1999, Hepatology.

[33]  R. Jove,et al.  Cell transformation by the viral src oncogene. , 1987, Annual review of cell biology.

[34]  Y. Tan,et al.  Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1. , 1998, Biochemical and biophysical research communications.

[35]  K. Zänker,et al.  Differences in the migration capacity of primary human colon carcinoma cells (SW480) and their lymph node metastatic derivatives (SW620). , 1998, Cancer letters.

[36]  Y. Shiratori,et al.  Reduced C‐terminal Src kinase activity is correlated inversely with pp60c‐src activity in colorectal carcinoma , 2001, Cancer.

[37]  M. Kasuga,et al.  High Expression of PRL-3 Promotes Cancer Cell Motility and Liver Metastasis in Human Colorectal Cancer , 2004, Clinical Cancer Research.

[38]  J. Dixon,et al.  Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling. , 2001, Biochemical and biophysical research communications.

[39]  Z. Zhang,et al.  Protein tyrosine phosphatases: prospects for therapeutics. , 2001, Current opinion in chemical biology.

[40]  A. Bardelli,et al.  Genetic analysis of the kinome and phosphatome in cancer , 2005, Cellular and Molecular Life Sciences CMLS.

[41]  G. Martin The hunting of the Src , 2001, Nature Reviews Molecular Cell Biology.

[42]  Kozo Nakamura,et al.  Overexpression of the csk gene suppresses tumor metastasis in vivo , 2000, International journal of cancer.

[43]  S. Semba,et al.  Expression of PRL-3 Phosphatase in Human Gastric Carcinomas: Close Correlation with Invasion and Metastasis , 2004, Pathobiology.

[44]  J. Parsons,et al.  Src family kinases, key regulators of signal transduction , 2004, Oncogene.

[45]  R. Taub,et al.  PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth , 1994, Molecular and cellular biology.